Aylin Irmak Kuruc

Aylin Irmak Kuruc

Auto-generated profile, based on publicly available information

Aylin Irmak Kuruc

Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine , Ankara

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2024 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
FKFurkan Kalayci
Furkan Kalayci
MYMetin Yigit
Metin Yigit
AKAylin Irmak Kuruc
Aylin Irmak Kuruc
TCTevfik Cevirici
Tevfik Cevirici
BABanu Celikel Acar
Banu Celikel Acar

7 September 2021 in Journal of Pediatric Intensive Care
Verified
Journal Article
Closed access
PDF file
HAHalise Akça
Halise Akça
FKFunda Kurt
Funda Kurt
AÇAyla Akça Çağlar
Ayla Akça Çağlar
AGAhmet Alptuğ Güngör
Ahmet Alptuğ Güngör
AKAylin Irmak Kuruç
Aylin Irmak Kuruç
EŞEmrah Şenel
Emrah Şenel
Coronavirus disease 2019 (COVID-19) is now a global pandemic. The aim of this study was to investigate the prevalence of COVID-19 in pediatric patients and to compare the characteristics of positive and negative patients. This study conducted from March to May 2020 in a tertiary children's hospital. Patients were included if they were under 18 years old and a SARS-CoV-2 polymerase chain reaction test had been performed. Of the 1,812 patients included in the study, 365 (20.1%) were positive for COVID-19. The median age was 102 months in the positive group, 70 months in the negative group (p < 0.001). The sex distribution was almost equal. Nearly all positive patients had been in close contact with a COVID-19 infected family household member (p < 0.001). The most common symptoms were fever (54.4%) and cough (38.6%). The asymptomatic patient rate was higher in the positive group (p < 0.001). Lymphopenia (<1500/mm3) was found in 29.9% of the positive children (p = 0.005). When the groups were compared, white blood cell, neutrophil, lymphocyte, and platelet counts; neutrophil-to-lymphocyte ratio; and C-reactive protein level were lower in the positive group. Chest radiography was performed in 95.3% of the positive patients, and the results of 29.7% of them were interpreted as pathological (p < 0.001). Most of the pediatric patients had a history of contact with COVID-19 positive individuals, and therefore, the diagnosis is generally suspected from a history of household exposure to COVID-19. Lymphopenia can help predict positivity. Awareness, reinforcing infection control measures, and performing health management within families are important steps to manage these patients. Received: 24 May 2021 Accepted: 28 July 2021 Publication Date: 07 September 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

11 June 2026 in Journal of Tropical Pediatrics
Verified
Journal Article
Open access
AKAylin Irmak Kuruc
Aylin Irmak Kuruc
Kubra AykacKubra Aykac
Kubra Aykac
ODOsman Oğuz Demir
Osman Oğuz Demir
GGGamze Gürsoy
Gamze Gürsoy
TATekin Aksu
Tekin Aksu
YOYasemin Ozsurekci
Yasemin Ozsurekci
Crimean–Congo hemorrhagic fever (CCHF) is a zoonotic viral infection that may present mildly in children but can progress to severe clinical states due to secondary hemophagocytic lymphohistiocytosis (HLH). We retrospectively analyzed the clinical, laboratory, and treatment data of children aged 0–18 years with polymerase chain reaction (PCR)-confirmed CCHF who were hospitalized at Hacettepe University, a large referral center for CCHF, between January 2019 and July 2025. Serial laboratory values (Days 0, 3, 7, and 10) and therapeutic interventions were evaluated. Twenty-two children (median age 13 years, 72% male) were included. The most frequent symptoms were fever (100%), bradycardia (59%), and conjunctival hyperemia (41%). HLH was diagnosed in 18 patients (82%). Ribavirin (91%), intravenous immunoglobulin (IVIG) (86%), and corticosteroids (68%) were administered. Platelet counts began to recover by Day 7, whereas ferritin declined gradually and normalized later. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels showed a progressive decrease. No patient required intensive care, and none died. Secondary HLH was highly prevalent among pediatric CCHF cases, yet outcomes were favorable with early antiviral and immunomodulatory therapy. Platelet recovery and delayed ferritin normalization may serve as practical biomarkers of disease resolution. Prospective multicenter studies with cytokine and viral-load profiling are warranted.

1 January 2026 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
Kubra AykacKubra Aykac
Kubra Aykac
OCOzlem Cakici
Ozlem Cakici
AKAylin Irmak Kuruc
Aylin Irmak Kuruc
CÖCanan Özlü
Canan Özlü
PKPınar Koc
Pınar Koc
YOYasemin Ozsurekci
Yasemin Ozsurekci

14 February 2022 in Journal of Pediatric Intensive Care
Verified
Journal Article
Closed access
PDF file
HAHalise Akça
Halise Akça
FKFunda Kurt
Funda Kurt
AÇAyla Akça Çağlar
Ayla Akça Çağlar
AGAhmet Alptuğ Güngör
Ahmet Alptuğ Güngör
AKAylin Irmak Kuruç
Aylin Irmak Kuruç
EŞEmrah Şenel
Emrah Şenel
It has been brought to the publisher's attention that the author names were listed incorrectly in the above article published in Journal of Pediatric Intensive Care, Volume 11, Number 1, 2022 (DOI: 10.1055/s-0041-1735493). The corrected names appear as above. Article published online: 22 November 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany